Stress cardiomyopathy secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
Stress cardiomyopathy is a self-limiting disease, which usually resolves within a few weeks. However, medical therapy may be necessary during the acute phase of the illness or when complications arise.
Secondary Prevention
- Stress cardiomyopathy is a self-limiting disease, which usually resolves within a few weeks.
- Medical therapy may be necessary during the acute phase of the illness or when complications arise.[1]
References
- ↑ Brunetti ND, Santoro F, De Gennaro L, Correale M, Kentaro H, Gaglione A, Di Biase M (2016). “Therapy of stress (takotsubo) cardiomyopathy: present shortcomings and future perspectives”. Future Cardiol. 12 (5): 563–72. doi:10.2217/fca-2016-0014. PMID 27538839.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
